No Data
List of Conversion Stocks (Part 1) [List of Parabolic Signal Conversion Stocks]
○ List of buy converted stocks in the market Code Stock name End price SAR TSE main board ＜1332＞ Nissui 938 886 ＜1605＞ INPEX 2009 1916 ＜1939＞ Yondenko 1360 1209 ＜1941＞ Chudenko 3385 3130 ＜1976＞ Myojo Kogyo 1319 1260 ＜1980＞ DaiDan 3020 2831 ＜2060＞ Feed One 8428 10 ＜2124＞ J
TD Cowen Maintains Takeda Pharmaceutical(TAK.US) With Buy Rating
Takeda Pharmaceutical Company Limited (TAK) Q2 2025 Earnings Call Transcript Summary
Takeda Pharmaceutical Company Limited (TAK) Q2 2025 Earnings Call Transcript
The Nikkei average started with a decrease of 576 yen, with Socionext and Fujitsu among others falling.
[Nikkei Stock Average・TOPIX (table)] Nikkei Average; 38504.35; -576.90 TOPIX; 2659.92; -35.59 [Opening Summary] The Nikkei Average on the 1st started trading with a decrease of 576.90 yen to 38504.35 yen and continued to decline. The U.S. stock market on the previous day, October 31, continued to decline. The Dow Jones Industrial Average closed at 41763.46, down 378.08 points, and the Nasdaq closed at 18095.15, down 512.78 points. The Core PCE Price Index exceeded financial estimates.
November 1st [Today's Investment Strategy]
[FISCO Selected Stocks] [Material Stocks] SCREEN Holdings <7735> 10,030 yen (10/31) Engaged in semiconductor manufacturing equipment such as wafer cleaning equipment. The earnings forecast for the fiscal year ending March 2025 has been revised upward. Operating profit is expected to be 113.5 billion yen (an increase of 20.5% from the previous year). It has been raised by about 8% from the previous forecast. This is the second upward revision of the full-year forecast for this fiscal year. The upward revision was due to factors such as the first-half operating profit of 58.2 billion yen (a 51.1% increase from the previous year), exceeding the previous forecast of 53 billion yen. "Year
No Data
No Data